Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Alpesh N. Amin, Sharon Cornelison, J. Andrew Woods & Nicola A. Hanania. (2022) Managing hospitalized patients with a COPD exacerbation: the role of hospitalists and the multidisciplinary team. Postgraduate Medicine 134:2, pages 152-159.
Read now
Read now
Nicola A Hanania, Scott Caveney, Tedi Soule, Lee Tombs, Sally Lettis, Courtney Crim, David M Mannino, Hitesh Patel & Isabelle H Boucot. (2021) Effect of Age on Efficacy and Safety of Fluticasone Furoate/Vilanterol (FF/VI), Umeclidinium (UMEC), and UMEC + FF/VI in Patients with Chronic Obstructive Pulmonary Disease: Analyses of Five Randomized Clinical Trials. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1925-1938.
Read now
Read now
Xiaoli Niu, Victoria Divino, Sanjay Sharma, Mitch Dekoven, Vamshi Ruthwik Anupindi & Carole Dembek. (2021) Healthcare resource utilization and exacerbations in patients with chronic obstructive pulmonary disease treated with nebulized glycopyrrolate in the USA: a real-world data analysis. Journal of Medical Economics 24:1, pages 1-9.
Read now
Read now
Igor Z Barjaktarevic & Aaron P Milstone. (2020) Nebulized Therapies in COPD: Past, Present, and the Future. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1665-1677.
Read now
Read now
Judith J Stephenson, Carole Dembek, Amanda Caldwell-Tarr, Rebecca M Conto, Mark Paullin & Edward M Kerwin. (2020) Observational Real-World Study to Assess Clinical Characteristics and Device Satisfaction in Patients with COPD Treated with Glycopyrrolate/eFlow® CS. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1713-1727.
Read now
Read now
Omar S Usmani. (2019) Choosing the right inhaler for your asthma or COPD patient. Therapeutics and Clinical Risk Management 15, pages 461-472.
Read now
Read now
Jill Ohar, Robert Tosiello, Thomas Goodin & Shahin Sanjar. (2019) Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 27-37.
Read now
Read now
James F Donohue, Donald A Mahler & Sanjay Sethi. (2019) Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2947-2958.
Read now
Read now
Gregor Anderson, Neil Johnson, Aruni Mulgirigama & Bhumika Aggarwal. (2018) Use of spacers for patients treated with pressurized metered dose inhalers: focus on the VENTOLIN™ Mini Spacer. Expert Opinion on Drug Delivery 15:4, pages 419-430.
Read now
Read now
Michael DePietro, Ileen Gilbert, Lauren A. Millette & Michael Riebe. (2018) Inhalation device options for the management of chronic obstructive pulmonary disease. Postgraduate Medicine 130:1, pages 83-97.
Read now
Read now
Josep Darbà, Gabriela Ramírez, Juan L García-Rivero, Sagrario Mayoralas, José Francisco Pascual, Diego Vargas & Adi Bijedic. (2017) Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax® compared with Turbuhaler® in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain. ClinicoEconomics and Outcomes Research 9, pages 127-137.
Read now
Read now
Daniel R Ouellette & Kim L Lavoie. (2017) Recognition, diagnosis, and treatment of cognitive and psychiatric disorders in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 639-650.
Read now
Read now
Michal Pirozynski & Tomasz R. Sosnowski. (2016) Inhalation devices: from basic science to practical use, innovative vs generic products. Expert Opinion on Drug Delivery 13:11, pages 1559-1571.
Read now
Read now
Francesco Blasi, Giorgio Walter Canonica, Stefano Centanni, Carlo Mereu, Roberto Bernabei, Giuseppe Paolisso, Raffaele Antonelli Incalzi, Angelo Corsico, Fabiano Di Marco, Manlio Milanese, Francesco Pagano, Pierachille Santus, Nicola Scichilone, Massimo Sumberesi, Fulvio Braido & Ilaria Baiardini. (2016) Genuair® Usability Test: Results of a National Public Survey of the Elderly. COPD: Journal of Chronic Obstructive Pulmonary Disease 13:3, pages 367-371.
Read now
Read now
Pinar Yildiz, Mesut Bayraktaroglu, Didem Gorgun & Funda Secik. (2016) Bronchodilator efficacy of 18 μg once-daily tiotropium inhalation via Discair® versus HandiHaler® in adults with chronic obstructive pulmonary disease: randomized, active-controlled, parallel-group, open-label, Phase IV trial. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2859-2867.
Read now
Read now
Donald P Tashkin. (2016) A review of nebulized drug delivery in COPD. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2585-2596.
Read now
Read now
Josep Darbà, Gabriela Ramírez, Antoni Sicras, Pablo Francoli, Saku Torvinen & Rainel Sánchez-de la Rosa. (2015) The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 2335-2345.
Read now
Read now
Soichiro Hanada, Shota Wada, Takeshi Ohno, Hirochiyo Sawaguchi, Masato Muraki & Yuji Tohda. (2015) Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 69-77.
Read now
Read now
Articles from other publishers (8)
Peter Haidl, Karsten Siemon & Jamal Mezrhab. (2022) COPD, Asthma und Co.. CME 19:5, pages 59-65.
Crossref
Crossref
Peter Haidl, K. Siemon & J. Mezrhab. (2021) Probleme bei der Inhalation im Alter. Pneumo News 13:6, pages 40-46.
Crossref
Crossref
Tahir KESKİN & Zeliha BAŞKURT. (2020) KOAH Tanılı Yaşlı Bireylerde Pulmoner RehabilitasyonPulmonary Rehabilitation in Elderly Individuals with COPD. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 8:1, pages 157-161.
Crossref
Crossref
Shaila H. Koppad, S. Anupama Kumar & K. N. Mohan Rao. 2020. Intelligent Data Communication Technologies and Internet of Things. Intelligent Data Communication Technologies and Internet of Things
538
545
.
Rachel O'Conor, Kimberly Muellers, Marina Arvanitis, Daniel P. Vicencio, Michael S. Wolf, Juan P. Wisnivesky & Alex D. Federman. (2019) Effects of health literacy and cognitive abilities on COPD self-management behaviors: A prospective cohort study. Respiratory Medicine 160, pages 105630.
Crossref
Crossref
Riju Ray, Lee Tombs, Michael J. Asmus, Isabelle Boucot, David A. Lipson, Chris Compton & Ian Naya. (2018) Efficacy of Umeclidinium/Vilanterol in Elderly Patients with COPD: A Pooled Analysis of Randomized Controlled Trials. Drugs & Aging 35:7, pages 637-647.
Crossref
Crossref
Christina Khaleel, Nurhayat Tabanca & Gerhard Buchbauer. (2018) α-Terpineol, a natural monoterpene: A review of its biological properties. Open Chemistry 16:1, pages 349-361.
Crossref
Crossref
Yung-An Tsou, Hung-Jin Huang, Wesley Wen-Yang Lin & Calvin Yu-Chian Chen. (2014) Lead Screening for Chronic Obstructive Pulmonary Disease of IKK2 Inhibited by Traditional Chinese Medicine. Evidence-Based Complementary and Alternative Medicine 2014, pages 1-16.
Crossref
Crossref